Bank Polska Kasa Opieki SA (0DP0)
London Exchange · UK · prices in PLN · close of 19 Oct 2026
Key indicators
| Last close | PLN 54.45 |
|---|---|
| 52-week range | 34.68 – 279.04 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +57.0% / +265.9% |
| Trend | Uptrend |
| RSI (14) | 100 |
| Volatility (1 year) | 45.0% |
| Worst drawdown (1 year) | 0.0% |
| Average daily value traded | 0.00M PLN |
| Dividend yield | 36.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bank Polska Kasa Opieki, commonly known as Pekao, is a commercial bank based in Warsaw, Poland. It serves individual customers, small businesses and larger corporate clients through a network of branches and digital channels. Its services include deposit accounts, mortgages and consumer loans, business lending, payment services, and investment and asset management products. The bank also offers treasury and brokerage services to institutional clients, and it operates as a universal bank across the Polish market.
Bank Polska Kasa Opieki SA trades under the code 0DP0 on the London Exchange in UK, with its price quoted in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bank Polska Kasa Opieki SA (0DP0) trades on the London Exchange in UK. It last closed at PLN 54.45 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 687 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 57.0% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 24.7% | ||
| From 52-week high | 0.0% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 57.0% | ||
| 12-month return, skipping the last month | 57.0% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 45.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | 0.0% | ||
| Liquidity | 5 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M PLN | ||
| Zero-volume days | 98.3% | ||
| Income | 70 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 36.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | +57.0% |
| 1 year | +57.0% |
| 3 years | +265.9% |
| 5 years | +341.2% |
Signals
| 50-day / 200-day average | 54.45 / 43.68 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 30.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Jun 2026 | PLN 19.7700 |
| 6 May 2025 | PLN 18.3600 |
| 23 Apr 2024 | PLN 19.2000 |
| 3 Jul 2023 | PLN 5.4200 |
| 22 Jul 2022 | PLN 4.3000 |
| 9 Sep 2021 | PLN 3.2100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.